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The central role of neutrophils in innate immunity and host defense has long been
recognized, and the ability of these cells to efficiently engulf and kill invading bacteria
has been extensively studied, as has the role of neutrophil apoptosis in resolution of
the inflammatory response. In the past few years additional immunoregulatory properties
of neutrophils were discovered, and it is now clear that these cells play a much greater
role in control of the immune response than was previously appreciated. In this regard,
it is noteworthy that Francisella tularensis is one of relatively few pathogens that can
successfully parasitize neutrophils as well as macrophages, DC and epithelial cells. Herein
we will review the mechanisms used by F. tularensis to evade elimination by neutrophils.
We will also reprise effects of this pathogen on neutrophil migration and lifespan as
compared with other infectious and inflammatory disease states. In addition, we will
discuss the evidence which suggests that neutrophils contribute to disease progression
rather than effective defense during tularemia, and consider whether manipulation of
neutrophil migration or turnover may be suitable adjunctive therapeutic strategies.
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NEUTROPHILS IN INNATE HOST DEFENSE
Polymorphonuclear leukocytes (PMNs) are the most abundant
leukocyte population in human blood and are rapidly mobi-
lized to sites of infection (Kennedy and Deleo, 2009). In this
locale they phagocytose microbes and utilize a combination of
NADPH oxidase-derived reactive oxygen species (ROS), cyto-
toxic granule components and antimicrobial peptides to generate
a highly lethal intraphagosomal environment (Nauseef, 2007;
Kennedy and Deleo, 2009). In contrast to other leukocytes,
neutrophils are short-lived and are preprogrammed to undergo
constitutive (spontaneous) apoptosis 18–24 h after release into
circulation, and under normal circumstances, PMN apoptosis
is further accelerated by phagocytosis and oxidant production
(Watson et al., 1996; Kobayashi et al., 2003c; Kobayashi and
Deleo, 2009). Ground-breaking studies of DeLeo and colleagues
revealed that both constitutive and infection-induced PMN death
are controlled not only at the level of intracellular signaling,
but also by global changes in gene expression (Kobayashi et al.,
2002, 2003a,c), discoveries which necessitated revision of the
long-standing notion that mature neutrophils were nearly tran-
scriptionally inert (Jack and Fearon, 1988; Kobayashi and Deleo,
2009). Tight spatial and temporal control of PMN apoptosis
is critical for elimination of infection and resolution of the
inflammatory response, and during this process phagocytic and
proinflammatory capacity are down-regulated, release of toxic
cell components is prevented, and tissue damage is minimized
(Kobayashi et al., 2003b,c; Fox et al., 2010). If this process is
perturbed PMNs can develop a proinflammatory phenotype that
Abbreviations: ATII, alveolar type II cells; CDK, cyclin-dependent kinase; COPD,
chronic obstructive pulmonary disease; DAMPs, danger-associated molecular
patterns; LVS, live vaccine strain; MMP-9, matrix metalloproteinase-9; PICD,
phagocytosis-induced cell death; PMN, Polymorphonuclear leukocyte; ROS, reac-
tive oxygen species.
promotes necrosis and granuloma formation and sustains infec-
tion (Kobayashi et al., 2003b, 2004). For this reason, defects in
PMN turnover are indicative of an ineffective and dysregulated
inflammatory response (Nathan, 2002). In keeping with this,
recent studies revealed that neutrophils have immunoregulatory
properties that directly influence the function of NK cells, DCs,
macrophages and lymphocytes (Mantovani et al., 2011).
NEUTROPHILS AND TULAREMIA PATHOGENESIS
Francisella tularensis is a facultative intracellular pathogen that is
distributed throughout the Northern hemisphere and two sub-
species of this bacterium, F. tularensis subspecies tularensis (type
A) and F. tularensis subspecies holarctica (type B) account for
nearly all cases of human tularemia. Most studies of this organism
have focused on macrophages as major vehicles for intracellular
growth and bacterial dissemination from sites of infection to the
liver and spleen (Chong and Celli, 2010). Nevertheless, F. tularen-
sis is unusual in its ability to infect neutrophils and epithelial cells
as well as mononuclear phagocytes, but relatively little is known
about the shared and distinct contributions of these other cell
types to disease (McLendon et al., 2006).
Aerosol infection of rhesus monkeys with virulent type B
F. tularensis strains defined prominent features of pneumonic
tularemia, and these studies were among the first to suggest a
key role for neutrophils in tissue destruction and disease pro-
gression (Tulis et al., 1970; Schricker et al., 1972; Hall et al.,
1973). These data demonstrate that large numbers of PMNs are
present the lungs, and from day 2 onward alveoli and bronchi-
oles become progressively clogged with neutrophils, bacteria and
necrotic debris. Granulomas also begin to organize wherein live
PMNs, bacteria and necrotic debris become enveloped by epithe-
lial syncytia. A similar disease course has been described using
rats, rabbits and mice (Dunaeva and Shlygina, 1975), and ex
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vivo analyses indicate that PMNs contain viable bacteria. Rhesus
monkeys, rabbits, mice (and many humans) do not survive
acute infection with type A F. tularensis (Eigelsbach et al., 1962;
Schricker et al., 1972). These organisms replicate much faster than
type B isolates, and progression to moribund status is character-
ized by an accumulation of neutrophils and bacteria in the lung
and extensive necrotic tissue damage (Conlan et al., 2003; Lamps
et al., 2004; Bosio et al., 2007). In keeping with the histopathology
data, flow cytometry analysis of mouse lung cells indicates that
whereas alveolar macrophages account for ∼70% of F. tularen-
sis-infected lung cells on the first day of infection, neutrophils are
the major infected cell population by day 3, and the fraction of
infected DCs and alveolar type II (ATII) cells is relatively low (Hall
et al., 2008).
It has long been known that neutropenia or inherited defects
in PMN function markedly increase susceptibility to infection.
For this reason, neutrophil-depleting antibodies are often used
to determine the role of this cell type in different diseases.
Results of studies that used the first antibody developed for this
purpose, RB6-8C5, suggested that PMNs are critical for host
defense against F. tularensis (Sjostedt et al., 1994). However, sub-
sequent studies revealed that RB6-8C5 causes depletion of both
inflammatory monocytes and PMNs, necessitating a reinterpre-
tation of prior results (Daley et al., 2008; Dunay et al., 2010).
A subsequent study that used a lower dose of RB6-8C5 that
is somewhat more selective for PMNs did not identify a role
for these cells in control of F. tularensis (Kuolee et al., 2011).
Using a different approach, Malik et al. discovered that inhibi-
tion of PMN migration into the lung allowed mice to survive
what would otherwise be a lethal dose of type A F. tularen-
sis or the live vaccine strain (LVS) (Malik et al., 2007). At the
same time, studies of Elkins and colleagues suggest that tularemia
severity is significantly increased under conditions that induce
neutrophilia, and this correlates directly with enhanced hepato-
toxicity (Bosio and Elkins, 2001; Mellilo et al., 2013). On bal-
ance, the data indicate that PMNs do not contribute to effective
host defense during tularemia, and instead contribute to disease
progression.
NEUTROPHIL CHEMOTAXIS
Mechanisms of neutrophil migration to sites of infection have
been extensively studied (Craig et al., 2009; Balamayooran et al.,
2010; Sadik et al., 2012; Fullerton et al., 2013). In the lung, inhaled
bacteria typically interact with alveolar macrophages and ATII
cells, and signaling downstream of pattern recognition receptors,
including TLRs, triggers secretion of major neutrophil chemo-
tactic agents, particularly IL-8 (CXCL8) in humans and KC in
mice, as well as GRO-α, MIP-2 and MCP-1. Additional play-
ers include IL-1β, LIX/CXCL5, G-CSF, complement factor C5a
and the eicosanoids LTB4 and PGE2, as well as Proline-Glycine-
Proline (PGP), a peptide generated from collagen in the extracel-
lular matrix by matrix metalloproteinases MMP-8 and MMP-9.
As neutrophil function and phenotype are affected by the mech-
anism of recruitment, it is noteworthy that IL-8, KC, GRO-α,
MIP-2, LIX, and PGP all bind CXCR1 and/or CXCR2 on PMNs.
Neutrophils directly contribute to this process as well via secretion
IL-8, IL-1β, LTB4, and MMP-9.
During tularemia a select subset of signals trigger PMNmigra-
tion into the lung as the amount of IL-8 released by infected
ATII cells, macrophages and endothelial cells is relatively low, and
neither IL-8 nor MCP-1 appears to be essential (Gentry et al.,
2007; Moreland et al., 2009). In marked contrast, F. tularen-
sis specifically stimulates expression of MMP-9, and PGP is a
major PMN chemoattractant in this system, as lung PMNs are
markedly diminished in MMP-9 null mice and these animals are
able to survive what would otherwise be a lethal dose of type A
F. tularensis or the LVS (Malik et al., 2007), as noted above. In
this regard, it is of interest that PGP is sufficient to recruit and
maintain tissue neutrophils in in absence of other chemotactic
agents and its stability and activity are enhanced by N-acetylation
(Snelgrove et al., 2010), but whether this modification is induced
during tularemia is unknown. PGE2 is produced by F. tularen-
sis-infected macrophages and ATII cells (Woolard et al., 2007)
and infected PMNs upregulate IL-1β (Schwartz et al., 2013), but
the extent to which these agents contribute to PMN chemo-
taxis and phenotypic modulation during tularemia remains to
be determined. A model that integrates these data is shown in
Figure 1.
F. tularensis DISRUPTS NEUTROPHIL DEFENSE
MECHANISMS
Francisella tularensis lipopolysaccharide (LPS) has an atypical
structure that does not signal through toll like receptors 4 or 2.
Nevertheless, LPS O-antigen and capsular polysaccharides act in
concert to protect this organism from the lytic effects of serum
complement (McLendon et al., 2006). This is significant as neu-
trophil uptake of F. tularensis is markedly enhanced by comple-
ment factors in normal human serum, and under these conditions
phagocytosis is mediated by complement receptor 1 and comple-
ment receptor 3 (Schwartz et al., 2012b). Neutrophil receptors
that confer inefficient phagocytosis of unopsonized F. tularensis
remain obscure.
Under normal circumstances, phagocytosis is coupled to rapid
activation of the Nox2 NADPH oxidase complex, such that toxic
oxidants kill most bacteria within 60min of infection (Deleo
et al., 1999; Kobayashi et al., 2003a; Nauseef, 2007). In marked
contrast, we and others demonstrated using several strains of
type A and type B F. tularensis as well as LVS that this organism
does not trigger a respiratory burst in human or monkey PMNs
(Proctor et al., 1975; McCaffrey and Allen, 2006; McCaffrey et al.,
2010). At the molecular level, forming F. tularensis phagosomes
exclude flavocytochrome b558, which contains the catalytic core
of the NADPH oxidase and also acts as a docking site in the mem-
brane for the cytosolic subunits that are also essential for ROS
production (McCaffrey and Allen, 2006; McCaffrey et al., 2010).
Within minutes, the ability of infected PMNs to be activated by
heterologous particulate and soluble stimuli is also profoundly
impaired, and in this case F. tularensis acts at a later stage to inhibit
the activity of enzyme complexes at the membrane (McCaffrey
and Allen, 2006; McCaffrey et al., 2010). A similar, if not iden-
tical, mechanism of post-assembly NADPH oxidase inhibition
also undermines the ability of specific IgG in anti-F. tularen-
sis immune serum to enhance bacterial killing via neutrophil
activation (McCaffrey and Allen, 2006; McCaffrey et al., 2010).
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FIGURE 1 | Model of neutrophil dynamics in the F. tularensis-infected
lung. Inhaled F. tularensis rapidly infects alveolar type II (ATII) cells and
macrophages (AM) (Gentry et al., 2007). (1) MMP-9, likely secreted by ATII
cells, cleaves collagen, generating PGP which directly stimulates PMN
recruitment from the bloodstream (Malik et al., 2007). (2) PMN migration is
also stimulated by direct infection of pulmonary endothelial cells (EC) by an
IL-8 and MCP-1-independent mechanism (Moreland et al., 2009). (3) F.
tularensis stimulates release of PGE2 and IL-8 from AM and ATII cells
(Gentry et al., 2007; Woolard et al., 2007). PGE2 stimulates macrophage
production of IL-10 (Hunt et al., 2012). (4,5) F. tularensis infects PMNs and
upregulates IL-1β (Schwartz et al., 2013). The extent to which PGE2, IL-8 and
IL-1β contribute to PMN chemotaxis and phenotypic modulation during
tularemia remains to be determined (dotted black arrows). (6,7) F. tularensis
inhibits PMN NADPH oxidase activity and prevents changes in gene
expression that are critical for constitutive and phagocytosis-induced
apoptosis (McCaffrey and Allen, 2006; McCaffrey et al., 2010; Schwartz et al.,
2012a, 2013). (8) Efferocytosis of apoptotic PMNs is critical for control of
infection and resolution of inflammation. Defects in apoptosis favor PMN
necrosis, and subsequent release of cytotoxic cell components, and danger
molecules such as HMGB1 exacerbate tissue destruction. Recent data
suggest that efferocytosis and/or clearance of necrotic cell debris may be
impaired (Mares et al., 2011) (dotted gray arrows).
Evasion of toxic oxidants at early stages of infection is followed
by phagosome egress, and release of bacteria into neutrophil
cytosol, and F. tularensis replicates to some extent in this locale,
though but not to the same extent as in macrophages (McCaffrey
and Allen, 2006; Schulert et al., 2009; Schwartz et al., 2012a;
Long et al., 2013). FevR and MigR, major virulence regulators of
F. tularensis, are essential for inhibition of neutrophil activation
(Buchan et al., 2009; McCaffrey et al., 2010). The genes in the
MigR/FevR regulon required for NADPH oxidase inhibition are
as yet unknown, but are distinct from pathogenicity island genes
required for phagosome escape and intracellular growth such as
iglI and iglJ (McCaffrey et al., 2010; Long et al., 2013). Other genes
such as carA, carB, and pyrB act indirectly via effects on pyrimi-
dine biosynthesis (Schulert et al., 2009), and the role of the acid
phosphatase AcpA in NADPH oxidase inhibition and virulence
is controversial (Reilly et al., 1996; Child et al., 2010; McCaffrey
et al., 2010; Mohapatra et al., 2010).
F. tularensis PROLONGS NEUTROPHIL LIFESPAN VIA
EFFECTS ON SIGNALING AND GENE EXPRESSION
Neutrophils are short-lived and undergo constitutive apoptosis at
a rate of 1011 cell per day in humans (Kennedy and Deleo, 2009).
Although the specific events that initiate constitutive PMN apop-
tosis are unknown, it is clear that cell death is tightly regulated
and that both intrinsic and extrinsic pathway caspases contribute
to this process along with complex changes in gene expression
that comprise and “apoptosis differentiation program,” as noted
above. Since the seminal studies of Watson (Watson et al., 1996)
it has also been clear that phagocytosis and NADPH oxidase-
derived ROS profoundly accelerate PMN apoptosis as compared
with unstimulated controls (Kobayashi et al., 2003a, 2004). This
“phagocytosis-induced cell death” (PICD) respone is also regu-
lated at the level of gene expression, and is critical for effective
host defense. Blockade of NADPH oxidase activity by F. tularen-
sis suggested that this organism may not accelerate PMN death,
and as such may not induce PICD. Indeed, our recent biochemi-
cal studies and analysis of PMN gene expression provide definitive
evidence that F. tularensis not only fails to induce PICD, but
also inhibits constitutive neutrophil apoptosis via effects on the
intrinsic and extrinsic pathways, and in this manner profoundly
prolongs cell lifespan (Schwartz et al., 2012a, 2013)
Specifically, the biochemical data indicate that the vast major-
ity of infected PMNs do not progress to an apoptotic morphology
within 48 h of infection with live F. tularensis, and in keep-
ing with this PS externalization, processing and activation of
caspases-8, −9, and −3, and DNA fragmentation are markedly
impaired (Schwartz et al., 2012a). At the same time, F. tularen-
sis significantly alters the expression of over 3400 human neu-
trophil genes between 3 and 24 h of infection, including 365
unique genes linked to apoptosis and cell survival (Schwartz
et al., 2013). Of particular note are effects of F. tularensis on
BAX, a proapoptotic member of the Bcl-2 family of proteins
that plays a pivotal role in the intrinsic apoptotic pathway via
disruption of the outer mitochondrial membrane. Upregulation
of BAX is a hallmark of the PICD response (Kobayashi et al.,
2002, 2003a, 2004). However, BAX mRNA and protein are
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progressively downregulated by F. tularensis (Schwartz et al.,
2013). It is therefore likely that blockade of the respiratory burst
and downregulation of BAX synergize to prevent PICD during
F. tularensis infection. At the same time, upregulation of sev-
eral prosurvival factors and anti-apoptosis genes collaborate to
diminish and delay the constitutive apoptosis program in PMN.
Although not all of these data can be discussed here, sustained
expression BIRC4, which encodes X-linked inhibitor of apopto-
sis protein (XIAP), and CAST which encodes calpastatin, likely
account in large part for defective processing and activation of
intrinsic pathway caspases (Schwartz et al., 2013). At the same
time not all genes associated with enhanced PMN survival are
modulated by this pathogen, as expression of IL-8 (CXCL8) is
not induced and this cytokine is not secreted by PMNs infected
with live F. tularensis (Schwartz et al., 2012a, 2013). In contrast,
IL-8 appears critical for sustained survival of neutrophils infected
with the obligate intracellular pathogen Chlamydia pneumoniae
(van Zandbergen et al., 2004), and as such the data indicate that
these two pathogens use distinct mechanisms to modulate PMN
lifespan.
It is also important to note that apoptosis normally down-
regulates PMN functional capacity, and if apoptosis is inhib-
ited these cells exhibit a sustained proinflammatory phenotype
(Kobayashi et al., 2003b; Kennedy and Deleo, 2009). Consistent
with this, F. tularensis-infected PMNs show enhanced expression
of VEGF, IL6, IL1B, CXCL1, OSM, and IL1RN (Schwartz et al.,
2013). Together, enhanced lifespan and proinflammatory capac-
ity increase the probably of cell progression to secondary necrosis,
which is characterized by spilling of DAMPs, alarmins, and other
cytotoxic molecules that further amplify inflammation and cause
extensive host tissue destruction (Kobayashi et al., 2003c; Fox
et al., 2010; Silva, 2010).
TARGETING PMNs AS A CANDIDATE ADJUNCTIVE
THERAPUTIC STRATEGY
Neutrophil accumulation and enhanced longevity, granuloma
formation, and extensive tissue necrosis are benchmarks that
define a defective inflammatory response (Nathan, 2002), and are
also characteristic features of tissues infected with F. tularensis
(Tulis et al., 1970; Schricker et al., 1972; Hall et al., 1973). The
fact that blockade of PMN influx into the lung favors host sur-
vival without markedly altering tissue bacterial load (Malik et al.,
2007) is consistent with an immunoregulatory role for PMNs in
tularemia pathogenesis (Mantovani et al., 2011), as are the effects
of F. tularensis on neutrophil activation state, lifespan and proin-
flammatory capacity that are noted above and summarized in
Figure 1. Considered together, the data support a model in which
neutrophils play a unique role in tularemia pathogenesis via dys-
regulation of the inflammatory response that is distinct from
the role of macrophages as major vehicles for bacterial growth
and dissemination. Thus, suitable points of therapeutic inter-
vention may include PMN chemotaxis, apoptosis or activation
state.
Inhibition of PMN apoptosis and aggressive neutrophilic
inflammation also exacerbate the severity of pneumococcal
meningitis (Koedel et al., 2009) and contribute significantly to
lung destruction in human patients with chronic obstructive
pulmonary disease (COPD) (Weathington et al., 2006). As in
tularemia, PMN accumulation in the lungs of humans with
COPD is driven by MMP-9-dependent production of PGP, and
published data suggest that targeting this pathway with anti-PGP
antibodies suppresses neutrophil responses and appears to have
some therapeutic benefit in mouse COPD models (Weathington
et al., 2006). Similarly, Arginine-Threonine-Arginine peptides
block IL-8 and PGP signaling at the level of CXCR1 and
CXCR2 to inhibit PMN migration and activation, and in this
manner ameliorate lung destruction during emphysema (van
Houwelingen et al., 2008). Other interventions that directly tar-
get this mechanism of PMN chemotaxis include small molecule
inhibitors of MMPs such as GM6001, CP-471,474, and RS113,456
and enhancement of endogenous mechanisms of MMPs inhi-
bition via intratracheal delivery of recombinant TIMPs (tissue
inhibitors of metalloproteinases) (Djekic et al., 2009). As protein-
based therapeutics are very expensive they are not optimal for
treatment of chronic illnesses, yet could be of considerable
benefit in the context of acute infectious diseases, including
tularemia.
Other potential therapeutic targets include lipid mediators of
the eicosanoid family, which are dysregulated in many critical ill-
nesses. In particular, resolvin E1 is of interest as it is effective
at concentrations as low as 1 nM, is beneficial for treatment of
aspiration pneumonia, and is known to decrease lung PMNs via
effects on ROS production, PICD and efferocytosis (Fullerton
et al., 2013). Aspirin-triggered resolvins also appear to reduce
mortality associated with systemic inflammatory response syn-
drome. On the other hand, excess or sustained production of
PGE2 by macrophages and epithelial cells induces a state of
“injurious resolution” that compromises Fc receptor function
and NADPH oxidase activity and alters macrophage pheno-
type. This condition can occur in burn patients or infection
with Aspergillus, and is reversed in by aspirin or cyclooxyge-
nase inhibitors which reduce PGE2 levels by 95% (Fullerton
et al., 2013). Although further analysis of eicosanoid pro-
files during tularemia is needed, these lipid mediators are of
interest as PGE2 is induced by F. tularensis and dampens at
least some aspects of the immune response (Woolard et al.,
2007).
Other studies have begun to examine the potential therapeu-
tic utility of PMN apoptosis induction. Cyclin-dependent kinases
(CDKs) regulate growth of most cell types, yet are critical regu-
lators of PMN viability and lifespan (Witko-Sarsat et al., 2011).
Inhibition of CDKs with R-roscovitine and other related com-
pounds can induce apoptosis and resolution of PMN-dominant
inflammatory responses (Leitch et al., 2010), and in this man-
ner accelerate recovery of mice with pneumococcal meningi-
tis (Koedel et al., 2009). Moreover, our recent data indicate
that CDK7 and CDK2 are induced in PMNs by F. tularensis
(Schwartz et al., 2013). In summary, given the potentially short
widow between the onset of symptoms, severe disease and death,
future studies should consider whether agents that modulate
PMN chemotaxis, directly target PMN apoptosis, or modulate
the inflammatory response may be useful as adjunctive thera-
peutic agents when combined with antibiotics for treatment of
tularemia.
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RELEVANCE TO OTHER INFECTIOUS DISEASES
As in tularemia, PMNs are the most commonly infected cell type
in the airway of persons infected with Mycobacterium tuberculo-
sis (Lowe et al., 2012). PMN lifespan is prolonged, and protective
CD4+ T cell-driven adaptive immune responses are curtailed at
the level of DCs, as downstream responses are less efficient when
these cells are directly infected than when antigens are acquired by
efferocytosis of apoptotic, infected PMNs (Blomgran and Ernst,
2011). Thus, neutrophilia is associated with impaired control of
infection and correlates directly with the severity of cavitary dis-
ease and tissue damage. Neutrophils may kill someM. tuberculosis
early in infection, but PMN depletion at later stages appears to be
beneficial (Lowe et al., 2012). Many factors drive PMN accumula-
tion during tuberculosis including macrophage and DC-derived
IL-8, G-CSF, and LTB4, as well as IL-1β, IL-8, and LTB4 from
PMNs themselves (Lowe et al., 2012). A role for PGE2 has also
been described, and MMP-9 may play a specific role in recruit-
ment of PMNs to granulomas (Lowe et al., 2012; Hawn et al.,
2013).
Brucella abortus replicates in an ER-derived vacuole in
macrophages. Similar to F. tularensis, B. abortus LPS has low
bioactivity, yet in contrast to F. tularensis, there are relatively few
PMNs in the circulation or at sites of infection (Barquero-Calvo
et al., 2007). At the same time, B. abortus is not efficiently killed by
human PMNs in vitro (Kreutzer et al., 1979), and neutrophils do
not appear to contribute directly to bacterial killing. Rather, con-
trol of infection is favored by PMN depletion during late stages of
infection, which enhances lymphocyte activation and proinflam-
matory cytokine production ((Barquero-Calvo et al., 2007, 2013).
Arthritis is a complication of B. abortus infection, and local secre-
tion of MMP-2 andMMP-9 plays an important role in neutrophil
recruitment and joint damage (Scian et al., 2011). In contrast,
C5a, IL-1β, and LTB4 play dominant roles in neutrophil-mediated
joint damage in rheumatoid arthritis (Sadik et al., 2012).
Finally, MMP-8 and MMP-9 also drive PMN recruitment to
the lungs during cystic fibrosis, and this is perpetuated and ampli-
fied byMMP-9 released by PMN degranulation. PGP, particularly
in its highly active N-acetylated form, is elevated in patient spu-
tum (Xu et al., 2011). Thus, strategies that target MMPs may also
be useful in this disease that is characterized by chronic neu-
trophilic inflammation. Considered together, the data summa-
rized here demonstrate that PMNs play complex and important
roles in infection, and therapeutic strategies that target this cell
type are being developed and may have wide utility alone or in
combination with antibiotics.
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